Use of Anakinra by the IV route is RESTRICTED to patients with compromised subcutaneous absorption and order entry will be restricted to Attending Rhematologists only. Administration will be restricted to IV push of the subcutaneous product undiluted. All use outside of this restriction will require the approval of the CMO or their delegate.
Use of Anakinra by the IV route is RESTRICTED to patients with compromised subcutaneous absorption and order entry will be restricted to Attending Rhematologists only. Administration will be restricted to IV push of the subcutaneous product undiluted. All use outside of this restriction will require the approval of the CMO or their delegate.